Invasive carcinoma of no special type
(Redirected from Mammary ductal carcinoma)
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
Invasive carcinoma of no special type | |
---|---|
![]() | |
Synonyms | Invasive ductal carcinoma, NOS |
Pronounce | N/A |
Specialty | Oncology |
Symptoms | Breast lump, nipple discharge, breast pain |
Complications | N/A |
Onset | Typically post-menopausal |
Duration | Variable |
Types | N/A |
Causes | Genetic mutations, hormonal factors |
Risks | Family history, age, hormone replacement therapy |
Diagnosis | Mammography, biopsy |
Differential diagnosis | Lobular carcinoma, ductal carcinoma in situ |
Prevention | N/A |
Treatment | Surgery, chemotherapy, radiation therapy, hormonal therapy |
Medication | N/A |
Prognosis | Variable, depends on stage and grade |
Frequency | Most common type of breast cancer |
Deaths | N/A |
Invasive Carcinoma of No Special Type (IC-NST), also known as Invasive Ductal Carcinoma (IDC) of no special type, is the most common form of breast cancer. It is characterized by cancer cells that have spread beyond the ducts into the surrounding breast tissue. This article provides an overview of IC-NST, including its pathology, diagnosis, treatment, and prognosis.
Pathology
IC-NST originates in the milk ducts of the breast and invades the fibrous or fatty tissue of the breast outside the duct. It is termed "no special type" because it does not have the specific features that characterize other types of breast cancer, such as lobular carcinoma or inflammatory breast cancer. Under the microscope, IC-NST is characterized by a lack of specialized features, but it may exhibit a wide range of differentiation and aggressiveness.
Diagnosis
The diagnosis of IC-NST typically involves a combination of imaging tests and a biopsy. Mammography and ultrasound are commonly used to detect abnormalities in the breast tissue. If these imaging tests reveal a suspicious area, a biopsy is performed to collect cells from the tumor for microscopic examination. The biopsy not only confirms the presence of cancer but also determines its type and grade.
Treatment
Treatment for IC-NST depends on the stage of the disease, the size of the tumor, the patient's age and general health, and other factors. Treatment options may include:
- Surgery: This may involve a lumpectomy (removal of the tumor and a small margin of surrounding tissue) or mastectomy (removal of one or both breasts).
- Chemotherapy: The use of drugs to kill cancer cells, often used before surgery (neoadjuvant chemotherapy) to shrink the tumor or after surgery (adjuvant chemotherapy) to kill any remaining cancer cells.
- Radiation therapy: The use of high-energy rays to target and kill cancer cells, typically used after surgery to eliminate any remaining cancer cells in the breast.
- Hormone therapy: For tumors that are hormone receptor-positive, medications that block hormones can be used to slow or stop the growth of cancer cells.
- Targeted therapy: For tumors that have certain genetic markers, targeted therapy drugs can be used to specifically attack cancer cells without harming normal cells.
Prognosis
The prognosis for patients with IC-NST varies depending on several factors, including the stage of the cancer at diagnosis, the tumor grade, and the patient's overall health. Early detection and treatment are crucial for improving the prognosis. The 5-year survival rate for breast cancer, in general, has been improving over the years due to advances in treatment and awareness.
Prevention and Screening
While there is no sure way to prevent IC-NST, certain lifestyle changes can reduce the risk of developing breast cancer. These include maintaining a healthy weight, exercising regularly, limiting alcohol consumption, and avoiding tobacco use. Regular screening through mammography can also help detect breast cancer at an early stage, when it is most treatable.
Gallery
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD